US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.715
  • +0.008+1.13%
Trading Feb 27 10:53 ET
258.32MMarket Cap-0.97P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Lexicon Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 6.479M--
Nov 12, 20242024/Q31.750M / 2.929M--
Aug 1, 20242024/Q21.647M / 3.436M--
May 2, 20242024/Q11.130M / 1.401M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 6.479M--
Nov 12, 20242024/Q31.750M / 2.929M--
Aug 1, 20242024/Q21.647M / 3.436M--
May 2, 20242024/Q11.130M / 1.401M--

Unlock Free Earnings Estimates

Lexicon Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 27, 2025

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data